$CAPR Legal News: Capricor Therapeutics Investors Are Notified to Protect Your Rights in The Filed Securities Fraud Class Action - September 28 Deadline is Approaching

Bleichmar Fonti & Auld LLP issued a solicitation notice regarding a class action lawsuit against Capricor Therapeutics, setting a September 28 lead plaintiff deadline. The complaint alleges securities fraud, specifically claiming Capricor made false statements concerning Deramiocel and the integrity of clinical data supporting its Biologics License Application.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.